Specificity: Anti-MITF recognizes a nuclear protein, which is expressed in the majority of primary and metastatic epithelioid malignant melanomas as well as in normal melanocytes, benign nevi, and dysplastic nevi. Immunogen: N-terminal fragment of human MITF protein